Advanced search
Publication Cover
Current Medical Research and Opinion Volume 38, 2022 - Issue 4
Submit an article Journal homepage
2,419
Views
2
CrossRef citations to date
0
Altmetric
Pharmacology

An anchored simulated treatment comparison of uptitration of amlodipine compared with a low-dose combination treatment with amlodipine 5 mg/bisoprolol 5 mg for patients with hypertension suboptimally controlled by amlodipine 5 mg monotherapy

Caroline Focha Global Epidemiology, Merck Healthcare KGaA, Darmstadt, GermanyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0254-5560
ORCID Icon,
Jan Feifela Global Epidemiology, Merck Healthcare KGaA, Darmstadt, GermanyORCID Iconhttps://orcid.org/0000-0003-3453-9365
ORCID Icon &
Ulrike Gottwald-Hostalekb Global Medical Affairs, Merck Healthcare KGaA, Darmstadt, GermanyORCID Iconhttps://orcid.org/0000-0002-0770-4743
ORCID Icon
Pages 587-593 | Received 21 Dec 2021, Accepted 13 Jan 2022, Published online: 01 Feb 2022

References

  • Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
  • Geddes JS. Calcium antagonists and beta blockade–a useful combination. Postgrad Med J. 1983;59 (Suppl 2):62–69.
  • Schrader J, Salvetti A, Calvo C, et al. The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg. Int J Clin Pract. 2009;63(2):217–225.
  • Drummond W, Munger MA, Rafique Essop M, et al. Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy. J Clin Hypertens Greenwich Conn. 2007;9(10):742–750.
  • EudraCT Number: 2019-000751-13. EU Clinical Trials Register; [cited 2021 Nov 26]. Available from: https://www.clinicaltrialsregister.eu/ctr-search/trial/2019-000751-13/PL.
  • Neldam S, Lang M, Jones R. Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study. J Clin Hypertens Greenwich Conn. 2011;13(7):459–466.
  • Phillippo DM, Ades AE, Dias S, et al. Methods for population-adjusted indirect comparisons in health technology appraisal. Med Decis Making. 2018;38(2):200–211.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
  • Boehringer Ingelheim. An Eight-week Randomized, 4-arm, Double-blind Study to Compare the Efficacy and Safety of Combinations of Telmisartan 40mg + Amlodipine 5mg Versus Telmisartan 80mg + Amlodipine 5mg Versus Amlodipine 5mg Versus Amlodipine 10mg Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With Amlodipine 5mg Monotherapy. Clinical Trial Registration NCT00558428, clinicaltrials.gov; [cited 2014 Oct 17]. Available from:https://clinicaltrials.gov/ct2/show/NCT00558428.
  • Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019; 366:l4898.
  • Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50(6):683–691.
  • Lumley T. Network Meta-analysis for indirect treatment comparisons. Stat Med. 2002;21(16):2313–2324.
  • Caro JJ, Ishak KJ. No head-to-head trial? Simulate the missing arms. PharmacoEconomics. 2010;28(10):957–967.
  • Ishak KJ, Proskorovsky I, Benedict A. Simulation and matching-based approaches for indirect comparison of treatments. PharmacoEconomics. 2015;33(6):537–549.
  • Phillippo DM, Dias S, Ades AE, et al. Assessing the performance of population adjustment methods for anchored indirect comparisons: a simulation study. Stat Med. 2020;39(30):4885–4911.
  • Phillippo D, Ades AE, Dias S, et al. NICE DSU Technical Support Document 18: Methods for population-adjusted indirect comparisons in submission to NICE. 2016. Available from: http://nicedsu.org.uk/wp-content/uploads/2017/05/Population-adjustment-TSD-FINAL.pdf
  • Campo C, Segura J, Ruilope LM. Factors influencing the systolic blood pressure response to drug therapy. J Clin Hypertens. 2002;4(1):35–40.
  • Kario K, Robbins J, Jeffers BW. Titration of amlodipine to higher doses: a comparison of Asian and Western experience. Vasc Health Risk Manag. 2013; 9:695–701.
  • Lindhorst J, Alexander N, Blignaut J, et al. Differences in hypertension between blacks and whites: an overview. Cardiovasc J Afr. 2007;18(4):241–247.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.